Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Metastatic castration-resistant prostate cancer (mCRPC) encompasses a heterogeneous wide range of molecular tumor behavior and a high risk of progression. Early detection and treatment are therefore crucial in these patients. Treatment has improved drastically in recent years and many novel therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Henríquez, Iván, Roach, Mack, Morgan, Todd M., Bossi, Alberto, Gómez, Junior A., Abuchaibe, Oscar, Couñago, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468423/
https://www.ncbi.nlm.nih.gov/pubmed/34572433
http://dx.doi.org/10.3390/biomedicines9091247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468423/
https://www.ncbi.nlm.nih.gov/pubmed/34572433
http://dx.doi.org/10.3390/biomedicines9091247

Ejemplares similares